Originally approved to help with excess weight and obesity, Wegovy and Ozempic, have become synonymous with weight loss fads. Here's what you need to know.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel full. When the drug interacts with a receptor in the stomach, patients feel full sooner and for a longer period of time after eating. The drug does not cause weight loss directly – instead, it makes you want to eat less.

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.

It seems as though Ozempic and other weight-loss jabs are everywhere – and the appetite for them shows no signs of slowing down – with the industry accelerating so fast it’s projected to be worth $100 billion within the next decade.

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads. Here's what you need to know.